Uetrecht JP[au] - Search Results

Year	Number of Results
1981	4
1984	1
1985	1
1987	2
1988	2
1989	2
1990	1
1991	2
1992	6
1993	4
1994	2
1995	6
1996	1
1997	3
1998	3
1999	3
2000	4
2001	2
2002	3
2003	2
2004	3
2005	5
2006	2
2007	2
2008	7
2009	3
2010	3
2011	2
2013	1
2014	1
2020	1
2021	1

1

Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development.

Regev A, Avigan MI, Kiazand A, Vierling JM, Lewis JH, Omokaro SO, Di Bisceglie AM, Fontana RJ, Bonkovsky HL, Freston JW, Uetrecht JP, Miller ED, Pehlivanov ND, Haque SA, Harrison MJ, Kullak-Ublick GA, Li H, Patel NN, Patwardhan M, Price KD, Watkins PB, Chalasani NP. Regev A, et al. Among authors: uetrecht jp. J Autoimmun. 2020 Nov;114:102514. doi: 10.1016/j.jaut.2020.102514. Epub 2020 Aug 5. J Autoimmun. 2020. PMID: 32768244 Free article. Review.

2

Nevirapine hypersensitivity.

Popovic M, Shenton JM, Chen J, Baban A, Tharmanathan T, Mannargudi B, Abdulla D, Uetrecht JP. Popovic M, et al. Among authors: uetrecht jp. Handb Exp Pharmacol. 2010;(196):437-51. doi: 10.1007/978-3-642-00663-0_15. Handb Exp Pharmacol. 2010. PMID: 20020271 Review.

3

Pathways of carbamazepine bioactivation in vitro. III. The role of human cytochrome P450 enzymes in the formation of 2,3-dihydroxycarbamazepine.

Pearce RE, Lu W, Wang Y, Uetrecht JP, Correia MA, Leeder JS. Pearce RE, et al. Among authors: uetrecht jp. Drug Metab Dispos. 2008 Aug;36(8):1637-49. doi: 10.1124/dmd.107.019562. Epub 2008 May 7. Drug Metab Dispos. 2008. PMID: 18463198 Free PMC article.

4

Reactive metabolites and agranulocytosis.

Uetrecht JP. Uetrecht JP. Eur J Haematol Suppl. 1996;60:83-8. doi: 10.1111/j.1600-0609.1996.tb01651.x. Eur J Haematol Suppl. 1996. PMID: 8987247 Review.

5

A fresh look at the mechanism of isoniazid-induced hepatotoxicity.

Metushi IG, Cai P, Zhu X, Nakagawa T, Uetrecht JP. Metushi IG, et al. Among authors: uetrecht jp. Clin Pharmacol Ther. 2011 Jun;89(6):911-4. doi: 10.1038/clpt.2010.355. Epub 2011 Mar 16. Clin Pharmacol Ther. 2011. PMID: 21412230 Review. No abstract available.

6

The danger hypothesis applied to idiosyncratic drug reactions.

Li J, Uetrecht JP. Li J, et al. Among authors: uetrecht jp. Handb Exp Pharmacol. 2010;(196):493-509. doi: 10.1007/978-3-642-00663-0_18. Handb Exp Pharmacol. 2010. PMID: 20020274 Review.

7

Metabolism of drugs by leukocytes.

Uetrecht JP. Uetrecht JP. Drug Metabol Drug Interact. 1994;11(4):259-82. doi: 10.1515/dmdi.1994.11.4.259. Drug Metabol Drug Interact. 1994. PMID: 12369752 Review.

8

Current trends in drug-induced autoimmunity.

Uetrecht JP. Uetrecht JP. Toxicology. 1997 Apr 11;119(1):37-43. doi: 10.1016/s0300-483x(96)03594-9. Toxicology. 1997. PMID: 9129193 Review.

9

Hepatic effects of duloxetine-I: non-clinical and clinical trial data.

Wernicke J, Pangallo B, Wang F, Murray I, Henck JW, Knadler MP, D'Souza DN, Uetrecht JP. Wernicke J, et al. Among authors: uetrecht jp. Curr Drug Saf. 2008 May;3(2):132-42. doi: 10.2174/157488608784529189. Curr Drug Saf. 2008. PMID: 18690991 Review.

10

Myeloperoxidase-mediated activation of xenobiotics by human leukocytes.

Hofstra AH, Uetrecht JP. Hofstra AH, et al. Among authors: uetrecht jp. Toxicology. 1993 Oct 5;82(1-3):221-42. doi: 10.1016/0300-483x(93)90066-2. Toxicology. 1993. PMID: 8236277 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results